$1.96 0.08 (+4.26%)
12/4/2009 11:26 AM

Ligand Pharmaceuticals, Inc. (LGND)

CAPS Rating: 3 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

Recs

1
Member Avatar ImmortalThanos (71.95) Submitted: 2/28/2008 11:26:10 AM : Underperform Start Price: $3.67 LGND Score: +31.17

Avoid this like the plague. This is another one of those "Jack Of All Trades" companies that never really gets anywhere. Skip this until they get a better mission statement developed.

Report this Post 0 Comments

Featured Broker Partners